Showing posts with label Lactate. Show all posts
Showing posts with label Lactate. Show all posts

Monday, October 17, 2016

Hyperlactatemia and Lactic Acidosis

I recently came across a young patient with unexplained hyperlactatemia. He came in with severe abdominal pain and was found to have a normal CT Abdomen with a background of ethanol related chronic pancreatitis . He was eventually admitted for pain relief and unexplained hyperlactatemia. So I went back and did a bit of reading on LACTATE...

What is Lactate?
Lactate is the normal endpoint of the anaerobic breakdown of glucose. Most of the lactate production occurs in skeletal muscle, bowel, brain, and RBCs. The lactate generated can be taken up by the liver and converted to glucose (via gluconeogenesis) or can be used as a primary oxidative fuel. In the setting of decreased tissue oxygenation, lactic acid is produced as the anaerobic cycle is utilized for energy production.



Evidence suggests increased morbidity and mortality for patients with  increasing lactate levels or a decreased rate of lactate clearance.


How is lactate cleared from our body?
Lactate is cleared from blood by thru liver, kidneys (10-20%) and skeletal muscles. The ability of the liver to consume lactate is concentration-dependent and progressively decreases as the level of blood lactate increases. 
Lactate producers: skeletal muscle, the brain, the gut, and the erythrocytes. 
Lactate metabolizers: Liver, the kidneys, and the heart.


Lactate v/s Lactic Acid and Hyperlactatemia v/s Lactic Acidosis.
Lactate is not synonymous with lactic acid, and hyperlactatemia is not synonymous with lactic acidosis.
Hyperlactatemia is defined as a persistent, mild to moderate (upto 4-5 mmol/L) increase in blood lactate concentration without metabolic acidosis. It can occur in the setting of adequate tissue perfusion, intact buffering systems, and adequate tissue oxygenation.

Lactic acidosis is characterized by persistently increased blood lactate levels (usually >5 mmol/L) in association with metabolic acidosis. Also, lactic acidosis may not necessarily produce acidemia in a patient. The development of lactic acidosis depends on the magnitude of hyperlactatemia, the buffering capacity of the body, and the coexistence of other conditions that produce tachypnea and alkalosis (eg, liver disease, sepsis). Thus, hyperlactatemia or lactic acidosis may be associated with acidemia, a normal pH, or alkalemia.

D-Lactate and L-lactate

L-lactate and D-lactate are the two isomeric forms of lactate.
L-lactate is the most commonly measured level, as it is the only form produced in human metabolism.

D-lactate is a byproduct of bacterial metabolism and may accumulate in patients with short-gut syndrome or in those with a history of gastric bypass or small-bowel resection

What causes an elevated lactate?
  1.   Tissue Hypoxia and Anaerobic Metabolism (Traditional school of thought)
  2.   Due to decreased clearance rather than increased production in sepsis
  3.   Secondary to down-regulating of pyruvate dehydrogenase in skeletal muscles by inflammatory mediators (Cytokines) and Catecholamines.




Is it possible to have hypoperfusion but a normal lactate level?
Short Answer- YES
For significant increase in blood lactate to occur, lactate must be released into the systemic circulation and the rate of production must exceed hepatic, renal, and skeletal muscle uptake. Therefore, regional hypoperfusion of tissues may be present despite normal blood lactate concentrations.

Types of Lactic Acidosis
  • Type A – Poor tissue perfusion or oxygenation of blood (eg, hypotension, cyanosis, cool and mottled extremities). It can be caused by the overproduction of lactate or the underutilization of lactate. For instance, muscular activity, seizures, ischemia, shock, hypoxemia, anemia, CO poisoning.

  • Type B - no clinical evidence of poor tissue perfusion or oxygenation exists.
  1. Type B1 occurs in association with systemic disease, such as renal and hepatic failure, diabetes and malignancy, thiamine deficiency, infection, pancreatitis, short bowel syndrome
  2. Type B2 is caused by several classes of drugs and toxins, including biguanides, alcohols, iron, isoniazid, zidovudine, and salicylates.
  3. Type B3 is due to inborn errors of metabolism.

List of Possible Causes
  •       Sepsis related Hypoperfusion and Mitochondrial Dysfunction
  •       Bowel ischemia
  •       Severe iron-deficiency anemia, Diabetes mellitus
  •       Liver disease, Kidney Disease
  •       Alcoholic Ketoacidosis, Pancreatitis
  •       Malignancy (leukemia, lymphoma, lung cancer)
  •       Seizures
  •       Heat stroke, Pheochromocytoma
  •       Thiamine deficiency (Remember this one during ICU rounds!)
  •       Inborn errors of metabolism - von Gierke disease, fructose-1,6-diphosphatase  deficiency, pyruvate carboxylase deficiency, pyruvate dehydrogenase deficiency, oxidative phosphorylation deficiency, and methylmalonic aciduria.
  •       MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and stroke like episodes) - Characterized by migraine like headaches, dementia, hearing loss, ataxia, and episodic vomiting



What drugs can cause an elevated lactate?
   Acetaminophen
   Alcohols and glycols (ethanol, ethylene glycol, methanol, propylene glycol)
   Antiretroviral nucleoside analogs (zidovudine, didanosine, lamivudine)
   Beta-adrenergic agents (epinephrine, ritodrine, terbutaline, salbutamol)
   Biguanides (phenformin, metformin)
   Cocaine
   Cyanogenic compounds (cyanide, nitroprusside)
   5-FU
   Iron, Isoniazid
   Propofol
   Salicylates
   Sulfasalazine
   Valproic acid


Click here to listen to Scott Weingart talking about Lactate

Take Home:

  • Get familiar with Type B causes of an elevated lactate
  • See the medication list and co-morbities while evaluating elevated lactate


Other Resources:
EMCrit/Pulmcrit on Lactate
Resus.me 


Author:

              
     Lakshay Chanana
     
     Speciality Doctor
     Northwick Park Hospital
     Department of Emergency Medicine
     England

     @EMDidactic


                                                        

Monday, June 27, 2016

Salbutamol induced hyperlactaemia

Case


24/F with a history of Asthma presented to the ED complaining of shortness of breath that progressively got worse over the past couple of days in-spite-of increased use of inhalers. She has been intubated twice before due to asthma exacerbations. She never smoked and denied having any pets. 



In the ED, she received prednisone and multiple doses of albuterol nebulizations. Physical exam showed mild distress, BP 110/70, PR 110/min RR 28/min. She was able to talk in full sentences and was saturating 100% on 2 liters. Her best peak flow was reportedly 400, and she only did 150. She had bilaterally decreased air entry and significant expiratory wheezing. 

ABG on arrival showed a lactate level of 3 with a peak flow of 220. With treatment, in spite of an improvement in her peak flow to 300, she looked more tachypneic and lactate level increased to 5.5. Rest of the labs and CXR were normal.





Discussion

Salbutamol/ Albuterol is a β2 agonist used for bronchodilation in asthma. Salbutamol causes lactic acidosis by a combination of factors, but the exact etiology remains unclear. It is probably due to its metabolic effects. By creating a hyperadrenergic state it enhances glycogenolysis and gluconeogenesis, leading to more glucose, enhanced glycolysis, and pyruvate production. At the same time, enhanced lipolysis and increased free fatty acids inhibit pyruvate dehydrogenase enzyme, preventing pyruvate from entering the Krebs cycle. This causes pyruvate reduction to lactate.







Reports of lactic acidosis induced by high dose beta agonists used for tocolysis and bronchodilation have been described in obstetric and asthmatic patients. 


What are the types of Lactic Acidosis?

Type A Lactic Acidosis occurs when oxygen delivery to the tissues is compromised. 

Type B Lactic Acidosis occurs when either lactate production is increased or lactate removal is decreased without obvious oxygen delivery problems. It occurs due to increase in both endogenous and exogenous catecholamines. Enhanced β2 receptor activation leads to increased glycogenolysis, gluconeogenesis, lipolysis and ultimately to increased conversion of pyruvate to lactic acid. Concurrent corticosteroid use may enhance the beta receptor sensitivity further potentiating the lactic acidosis. 

Conditions associated with type B lactic acidosis include inborn errors of metabolism (pyruvate dehydrogenase deficiency), systemic disorders (liver failure), and medications (ethanol, metformin, and corticoids). It has also been postulated that endogenous (distress) or exogenous (drugs) adrenergic stimulation may be associated with increased conversion of pyruvate to lactate. 


What are the common blood gas findings in Acute Asthma?
The common metabolic disturbances seen during an acute attack are respiratory alkalosis, followed by respiratory acidosis as patients get tired of breathing.


What are the possible causes of lactic acidosis in Asthma?
1. Pulsus paradoxus and intrinsic PEEP decrease cardiac output and venous return
2. Production of lactate by overworked respiratory muscles
3. Hyperadrenergic State (Beta 2 agonist-induced)


Why is it important for us to know about this?
Albuterol induced lactic acidosis creates a paradoxical situation where there is enhanced bronchodilation but worsening tachypnea as a result of compensation for metabolic acidosis. Acidosis results in hyperventilation which could be mistaken for poor response to treatment. Physicians might misinterpret this situation as worsening respiratory failure and give more albuterol, creating a vicious cycle and ultimately leading to respiratory failure. 

Serial peak flow measurements and examination is the ideal way to identify this situation.


Take Home:
While treating asthmatic patients for severe bronchospasm, when lungs sound clear following treatment but tachypnea persists, suspect albuterol-induced hyperlactatemia. 


References:

  1. Dodda, Venkata R., and Peter Spiro. "Can albuterol be blamed for lactic acidosis?." Respiratory care 57.12 (2012): 2115-2118.
  2. Stratakos G, Kalomenidis J, Routsi C, Papiris S, Roussos C. Transient lactic acidosis as a side effect of inhaled salbutamol. Chest. 2002 Jul;122(1):385-6
  3. Stratakos G, Kalomenidis J, Routsi C, Papiris S, Roussos C: Transient lactic acidosis as a side effect of inhaled salbutamol. Chest 2002; 122: 385–6Stratakos, G Kalomenidis, J Routsi, C Papiris, S Roussos, C 
  4. Prakash S, Mehta S: Lactic acidosis in asthma: Report of two cases and review of the literature. Can Respir J 2002; 9: 203–8Prakash, S Mehta, S 

Author:

              
     Lakshay Chanana
     @EMDidactic